🇺🇸 FDA
Pipeline program

M9466 Alone or in Combination in Advanced Solid Tumors (DDRiver 501)

MS202659_0001

Phase 1 other active

Quick answer

M9466 Alone or in Combination in Advanced Solid Tumors (DDRiver 501) for Advanced solid tumors is a Phase 1 program (other) at Merck Sharp and Dohme with 1 ClinicalTrials.gov record(s).

Program details

Company
Merck Sharp and Dohme
Indication
Advanced solid tumors
Phase
Phase 1
Modality
other
Status
active

Clinical trials